"Take More Risks, Fail Earlier" Says Asset-Hunting Novo Nordisk CEO
Executive Summary
Novo Nordisk's CEO tells Scrip why the Danish group's R&D approach must embrace risk earlier to ensure "differentiated" products in an increasingly competitive world.